Oral immunoadjuvant activity of lipophilic derivatives of N-acetylglucosaminyl- (1->4)-N-acetylmuramyl-L-alanyl-D-isoglutaminyl-(L)-2 ,6-meso-diaminopimeric acid-(D)-amide

Author: Ogawa T.   Shimauchi H.   Furuta R.   Kawata S.   Yokogawa K.   Kotani S.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.13, Iss.10, 1995-07, pp. : 887-889

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content